Formisano Luigi, Guida Natascia, Valsecchi Valeria, Cantile Maria, Cuomo Ornella, Vinciguerra Antonio, Laudati Giusy, Pignataro Giuseppe, Sirabella Rossana, Di Renzo Gianfranco, Annunziato Lucio
Division of Pharmacology, Department of Neuroscience, Reproductive and Dentistry Sciences, School of Medicine, "Federico II" University of Naples, Naples 80131, Italy, Division of Pharmacology, Department of Science and Technology, University of Sannio, 82100 Benevento, Italy, and.
IRCSS SDN, Naples 80131, Italy.
J Neurosci. 2015 May 13;35(19):7332-48. doi: 10.1523/JNEUROSCI.2174-14.2015.
The Na(+)-Ca(2+) exchanger 1 (NCX1) is reduced in stroke by the RE1-silencing transcription factor (REST), whereas it is increased in ischemic brain preconditioning (PC) by hypoxia-inducible factor 1 (HIF-1). Because ncx1 brain promoter (ncx1-Br) has five putative consensus sequences, named Sp1A-E, for the specificity protein (Sp) family of transcription factors (Sp1-4), we investigated the role of this family in regulating ncx1 transcription in rat cortical neurons. Here we found that Sp1 is a transcriptional activator, whereas Sp3 is a transcriptional repressor of ncx1, and that both bind ncx1-Br in a sequence-specific manner, modulating ncx1 transcription through the Sp1 sites C-E. Furthermore, by transient middle cerebral artery occlusion (tMCAO) in rats, the transcriptional repressors Sp3 and REST colocalized with the two histone-deacetylases (HDACs) HDAC1 and HDAC2 on the ncx1-Br, with a consequent hypoacetylation. Contrarily, in PC+tMCAO the transcriptional activators Sp1 and HIF-1 colocalized with histone acetyltransferase p300 on ncx1-Br with a consequent hyperacetylation. In addition, in neurons silenced with siRNA of NCX1 and subjected to oxygen and glucose deprivation (OGD) (3 h) plus reoxygenation (RX) (24 h), the neuroprotection of Class I HDAC inhibitor MS-275 was counteracted, whereas in neurons overexpressing NCX1 and subjected to ischemic preconditioning (PC+OGD/RX), the neurotoxic effect of p300 inhibitor C646 was prevented. Collectively, these results demonstrate that NCX1 expression is regulated by the Sp3/REST/HDAC1/HDAC2 complex in tMCAO and by the Sp1/HIF-1/p300 complex in PC+tMCAO and that epigenetic intervention, by modulating the acetylation of ncx1-Br, may be a strategy for the development of innovative therapeutic intervention in stroke.
钠钙交换体1(NCX1)在中风时因RE1沉默转录因子(REST)而减少,而在缺血性脑预处理(PC)中因缺氧诱导因子1(HIF-1)而增加。由于ncx1脑启动子(ncx1-Br)有五个假定的共有序列,命名为Sp1A-E,用于转录因子(Sp1-4)的特异性蛋白(Sp)家族,我们研究了该家族在调节大鼠皮质神经元中ncx1转录的作用。在此我们发现,Sp1是ncx1的转录激活因子,而Sp3是ncx1的转录抑制因子,二者均以序列特异性方式结合ncx1-Br,通过Sp1位点C-E调节ncx1转录。此外,通过大鼠短暂性大脑中动脉闭塞(tMCAO),转录抑制因子Sp3和REST与两种组蛋白去乙酰化酶(HDAC)HDAC1和HDAC2在ncx1-Br上共定位,导致低乙酰化。相反,在PC+tMCAO中,转录激活因子Sp1和HIF-1与组蛋白乙酰转移酶p300在ncx1-Br上共定位,导致高乙酰化。另外,在用NCX1的小干扰RNA(siRNA)沉默并经历氧糖剥夺(OGD)(3小时)加复氧(RX)(24小时)的神经元中,I类HDAC抑制剂MS-275的神经保护作用被抵消,而在过表达NCX1并经历缺血预处理(PC+OGD/RX)的神经元中,p300抑制剂C646的神经毒性作用被预防。总体而言,这些结果表明,在tMCAO中NCX1表达受Sp3/REST/HDAC1/HDAC2复合物调节,而在PC+tMCAO中受Sp1/HIF-1/p300复合物调节,并且通过调节ncx1-Br的乙酰化进行表观遗传干预可能是开发中风创新治疗干预措施的一种策略。